Posted by Equitymaster After opening weak, the Indian Indices have remained well below the dotted line during the morning trading session. Banking... ...http://www.equitymaster.com/tm/tm.asp?date=10/13/2014&title=Banks--engg-stocks-drag-down-markets
NEW DELHI: India's top drug maker Sun Pharmaceutical Industries has received a rap from the United States regulator for being lax in monitoring the... ...http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-raps-sun-pharmaceuticals-for-delay-in-follow-up-for-recalled-drugs-from-us-market/articleshow/44779097.cms
From the Wires Sep. 27, 2014 03:30 AM DALLAS, September 27, 2014 /PRNewswire/ -- MarketOptimizer.org adds PharmaPoint: Major Depressive... ...http://in.sys-con.com/node/3200928
Shares of Sun Pharmaceutical Industries on Friday increased 4.3% after a report by brokerage firm Credit Suisse said the company receiving a Form... ...http://www.dnaindia.com/money/report-sun-pharma-gains-on-report-form-483-may-not-lead-to-import-alert-2021807
Sun Pharmaceutical shares fell as much as 4.1% to touch an intra-day low of Rs789 apiece on BSE on Friday. Photo: Bloomberg Shares of Sun... ...http://www.livemint.com/Money/t7dxJpX7JhhjeDDzJjeTkK/Sun-Pharma-shares-fall-4-on-reports-of-Taro-drug-recall.html
Venlafaxine or Effexor could be a...